The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats.
about
The orexin-1 antagonist SB-334867 blocks antipsychotic treatment emergent catalepsy: implications for the treatment of extrapyramidal symptomsHow antipsychotics work-from receptors to reality.The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.Risk of osteoporosis and fracture incidence in patients on antipsychotic medication.Prolactin concentrations in newly diagnosed, antipsychotic-naïve patients with nonaffective psychosis.The pharmacokinetic and safety profiles of blonanserin in healthy Chinese volunteers after single fasting doses and single and multiple postprandial doses.Dose-dependent galactorrhea with quetiapine.Evaluation of N-desmethylclozapine as a potential antipsychotic--preclinical studies.Prolactin and dopamine: what is the connection? A review article.The facts about sexual (Dys)function in schizophrenia: an overview of clinically relevant findings.Review article: clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics.Predicting brain occupancy from plasma levels using PET: superiority of combining pharmacokinetics with pharmacodynamics while modeling the relationshipLow dose quetiapine induced galactorrhoea: a case report.Quetiapine-induced galactorrhea with normal prolactin level in an adult female patient.Targeting the dopamine D2 receptor in schizophrenia.Aripiprazole acts as a selective dopamine D2 receptor partial agonist.Iloperidone-induced Galactorrhea in a Middle-aged Female.Predictions of in vivo prolactin levels from in vitro K(i) values of D(2) receptor antagonists using an agonist-antagonist interaction model.Potential bias in testing for hyperprolactinemia and pituitary tumors in risperidone-treated patients: a claims-based studyA review of quetiapine in combination with antidepressant therapy in patients with depression.Clinical questions and uncertainty--prolactin measurement in patients with schizophrenia and bipolar disorder.Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.Prolactin Levels After Switching to Paliperidone Palmitate in Patients with SchizophreniaExpected clinical benefits of paliperidone extended-release formulation when compared with risperidone immediate-release.The Effects of Antipsychotics on Prolactin Levels and Women's Menstruation.The use of atypical antipsychotics beyond psychoses: efficacy of quetiapine in bipolar disorder.Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences.α-Lipoic acid interaction with dopamine D2 receptor-dependent activation of the Akt/GSK-3β signaling pathway induced by antipsychotics: potential relevance for the treatment of schizophrenia.Antipsychotic-induced DRD2 upregulation and its prevention by α-lipoic acid in SH-SY5Y neuroblastoma cells.Model-based approaches to increase efficiency of drug development in schizophrenia: a can't miss opportunity.Blood lactate levels as a biomarker of antipsychotic side effects in patients with schizophrenia.Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients.Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.Catatonia, neuroleptics and brain damage--a case report.Tardive dyskinesia in schizophrenia is associated with prolactin-related sexual disturbances.Modeling of prolactin response following dopamine D2 receptor antagonists in rats: can it be translated to clinical dosing?In-depth neuropharmacokinetic analysis of antipsychotics based on a novel approach to estimate unbound target-site concentration in CNS regions: link to spatial receptor occupancy.Frequency of hyperprolactinemia and its associations with demographic and clinical characteristics and antipsychotic medications in psychiatric inpatients in China.
P2860
Q24653930-30990899-B467-4AA9-BD57-383665848F10Q30457477-AF57EB9D-B019-4AFC-9ACB-3ADF751DB0D5Q33619940-D2B506FC-A8F9-40A3-9FD9-5E0C1364455EQ34026011-97A016A2-522C-4F3B-8763-ACD6A34AFE92Q34289021-02E886D1-66C0-4EAF-A437-4E3849EA6973Q34396345-60DBFCA7-13A9-44EB-B01E-650BA34FBCAEQ34511670-C23624D0-688D-4D17-BE8F-BE79CF4A76B4Q34590400-86B4AA72-0F04-4E9B-B39E-C07E12EBCFC8Q34778434-D3D6B8DE-5504-4F13-8EEB-C6A07FEDBF07Q35369968-F44C8C73-32E5-4080-BE8E-1D4B17F7549EQ35661061-B297FC33-4762-4443-A162-CF3FFBBAA223Q35866868-FD7F3AE3-71DF-4CCD-8E03-2E56FA609FD8Q35980754-1110ED1D-4E18-4A11-8A40-489FEBD17803Q36182678-B0A15E22-89B2-4DE5-9885-41A45B44857BQ36539461-20F7F58C-2FEF-485C-826F-253B48EC8DBAQ36821350-E905DEC2-6F3D-4B5B-83D4-6225899DD3F8Q36869411-125982E6-C3A3-48CB-AD0E-9B739535C610Q36910550-569B79F3-A5CE-4ED7-BEB7-48F655C600B6Q37112276-DFA1F4E8-A20D-437F-BEBA-3B7F98670C41Q37129835-6C58A7DD-94F7-4F67-B9F3-C1AC456AA657Q37162812-42AC191C-3667-4315-B3DB-9ABFDDD58784Q37224949-E274E9A0-C4EB-4E7F-BF7D-0F401850D983Q37361982-BF0CBEDA-228A-4A3F-8173-3E5230AA94D9Q37422493-2AB84E9B-6DFC-45AA-B2D0-CEBE676A2E37Q37456024-3C8C2EB1-FF99-42AF-8B39-9E834CFD2656Q37468555-ACF6CF99-6382-41B0-86F8-0C5102715E90Q37747570-4C4E0D85-18BB-4264-9408-3D4C3BEF6D68Q37999566-B42604BD-1369-4AD8-8061-F717E0BD95ACQ38100267-0FB33192-3268-46D0-BAD8-831EDDDDB5EAQ39279185-B2363FBA-B3B9-44AA-9901-D9E9E4F743F0Q39664514-538939DE-74EE-47CA-8963-C77B2E99A2ADQ39959170-371315D8-074F-49C1-A3F7-AFB2F20B9C9FQ41118477-082580A1-8DB1-4049-B1A3-1D390D5137EFQ43489252-BF89CB76-7588-4623-A9D4-03C77731E054Q45257719-E43B2A05-1D9A-462C-B40F-FD0B195E2C0AQ46533519-F49A02AC-F755-411A-BB32-40C21CDDFF68Q46947443-C6F25B71-B895-4D47-A44B-AA57FBD03A54Q47126919-BDF328E7-A460-4937-9245-EA7D192BEA1FQ48294616-12C8EE29-81F3-448C-ACED-82B3A6AA6ADDQ48397820-AD63F286-F83A-4D7B-B6E5-03162DE154A3
P2860
The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
The differential effects of at ...... rmacological analysis in rats.
@en
The differential effects of at ...... rmacological analysis in rats.
@nl
type
label
The differential effects of at ...... rmacological analysis in rats.
@en
The differential effects of at ...... rmacological analysis in rats.
@nl
prefLabel
The differential effects of at ...... rmacological analysis in rats.
@en
The differential effects of at ...... rmacological analysis in rats.
@nl
P2093
P356
P1476
The differential effects of at ...... rmacological analysis in rats.
@en
P2093
P304
P356
10.1124/JPET.102.035303
P407
P577
2002-09-01T00:00:00Z